Control of recurrent supraventricular tachycardia with amiodarone hydrochloride.
Amiodarone hydrochloride, a new antiarrhythmic agent, controlled a recurrent supraventricular arrhythmia, refractory to conventional medical treatment, in a 57-year-old patient with an anomalous conduction system and idiopathic cardiomyopathy. For the 11 months that the patient has been taking the drug her arrhythmia has not recurred. This drug has produced no important side effects in this patient.
D000638:Amiodarone / Q000008:administration & dosage / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001572:Benzofurans / Q000627:therapeutic use*; D002312:Cardiomyopathy, Hypertrophic / Q000150:complications; D002908:Chronic Disease; D004562:Electrocardiography; D005260:Female; D006329:Heart Conduction System / Q000002:abnormalities / Q000187:drug effects; D006801:Humans; D008875:Middle Aged
D000889:Anti-Arrhythmia Agents; D001572:Benzofurans; D000638:Amiodarone